Bioavailabilityof DFN-15 at 3 Different Doses Versus Comparator to Determine Dose-proportionality of DFN-15 in Healthy Volunteers Under Fasting Conditions
Latest Information Update: 18 Sep 2017
At a glance
- Drugs Celecoxib (Primary) ; Celecoxib
- Indications Migraine
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Dr Reddys Laboratories
- 26 Jul 2017 Primary endpoint (Maximum Plasma Concentration (Cmax) of DFN-15) has been met as per the results published in the Clinical Drug Investigation
- 26 Jul 2017 Primary endpoint (Area Under the Curve (AUC) [0-inf] of DFN-15) has been met as per the results published in the Clinical Drug Investigation
- 26 Jul 2017 Results published in the Clinical Drug Investigation